Physician profile
Margaret Macdowell
NPI 1437123288
$1,125.63
in general payments reported to CMS, 2019-2025
21 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.30 · 2020: $87.74 · 2021: $370 · 2022: $235 · 2023: $88.33 · 2024: $157 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $363.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $194.44 | 2021-2025 | Keytruda, Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $132.44 | 2020-2024 | |
| Astrazeneca Pharmaceuticals LP | $112.75 | 2020-2022 | |
| Glaxosmithkline, LLC. | $108.16 | 2021 | |
| Siemens Medical Solutions USA, INC. | $74.49 | 2024 | Varian Ethos Treatment Planning, Truebeam |
| Boston Scientific Corporation | $58.82 | 2022-2023 | Spaceoar Vue System - 10ml |
| Medtronic, INC. | $57.94 | 2021-2023 | Osteocool Rf Ablation System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.51 | 2021 | |
| Medtronic USA, INC. | $39.76 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $37.68 | 2025 | |
| Genzyme Corporation | $36.78 | 2019 | |
| Bioprotect Medical, INC. | $31.38 | 2025 | Bioprotect Balloon Implant System |
| Janssen Biotech, INC. | $29.51 | 2021-2022 | |
| Teleflex LLC | $28.20 | 2024 | |
| Novocure INC. | $23.18 | 2024 | Optune |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Palette Life Sciences, INC. | $20.80 | 2022 | |
| Kyowa Kirin, INC. | $19.86 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $19.00 | 2022 | |
| Myovant Sciences INC. | $18.50 | 2022 | |
| Mylan Institutional INC. | $16.05 | 2021 | |
| Tactile Systems Technology INC | $14.38 | 2025 | Nimbl, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Macdowell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.